- Lobbying
- David AND McIntosh
Lobbying Arrangements Results for 'David Mc Intosh'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details H.R. 6, the "21st Century Cures Act," specifically policy issues relating to combination pharmaceutical products. Policy issues relating to corporate tax reform, including international tax rules. |
Aralez Pharmaceuticals US, Inc. (formerly Pozen Inc.)
|
Ferguson Strategies, LLC | |||
Details Defense Department POW/MIA identification issues, specifically relating to Section 1509(f)(2)(d)(2) of the FY 2010 National Defense Authorization Act. |
Bode Technology Group, Inc.
|
Ferguson Strategies LLC | |||
Details FY 2010 appropriation cycle, IHS, and other related matters involving life and business on the Bad River Reservation |
Bad River Band of Lake Superior Chippewa
Native American Tribe |
International Government Relations Group | |||
Details Section 301 of the Trade Act of 1974. |
Prime Time Commerce, LLC
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
UroGen Pharma Ltd.
|
BAKER & HOSTETLER LLP | |||
Details CMS reimbursement issues relating to durable medical equipment suppliers. |
Care Concepts Louisiana, Inc.
|
Ferguson Strategies LLC | |||
Details Public policy issues that promote renewable energy, including for dual-use applications. |
Lightening Energy
|
Ferguson Strategies LLC | |||
Details Telecommunications policy, including as it relates to legislative and regulatory initiatives affecting broadband, video and wireless. |
Verizon Services Corp.
|
Ferguson Strategies LLC | |||
Details Regulatory and reimbursement issues relating to pharmaceutical products. |
Depomed Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and payment issues relating to medical technology manufacturers. |
Integra LifeSciences Corp.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Tyme Technologies, Inc.
|
BAKER & HOSTETLER LLP | |||
Details H.R. 6, the "21st Century Cures Act," specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry. |
Integra LifeSciences Corp.
|
Ferguson Strategies, LLC | |||
Details H.R. 6, the "21st Century Cures Act." Policy issues relating Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically Section 902 relating to the Breakthro... |
Advaxis, Inc.
|
Ferguson Strategies, LLC | |||
Details Policy issues relating to corporate tax reform, including international tax rules. |
Prudential Financial Inc.
|
Ferguson Strategies, LLC | |||
Details Health care reform legislation, including safety and data exclusivity issues regarding follow-on biologics. |
HOFFMANN-LA ROCHE INC.
|
Ferguson Strategies LLC | |||
Details Regulatory and public policy issues regarding Tricare reimbursement. |
AKRIMAX PHARMACEUTICALS, LLC
|
Ferguson Strategies LLC | |||
Details Broadcasting issues as related to FCC regulation |
National Football League
|
International Government Relations Group | |||
Details Healthcare policy; Medicare Part B. and essential health benefits requirements of Public Law 111-148, the Affordable Care Act; H.R. 1628, American Health Care Act |
Aeroflow Healthcare
|
BAKER & HOSTETLER LLP | |||
Details Issues related to the financing of energy projects |
American Municipal Power, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Financial services products, including mortgage-related insurance coverage. |
Venture Quest Capital Partners
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to capital markets and the clearance and settlement of securities transactions. |
Depository Trust & Clearing Corporation
|
BAKER & HOSTETLER LLP | |||
Details Policy issues relating to competitive bidding for durable medical equipment, including H.R. 1717, the "Medicare DMEPOS Market Pricing Program Act" and H.R.2375, the "Transparency and Accountability... |
US Healthcare Supply, LLC
|
Ferguson Strategies, LLC | |||
Details Legislation to create a national electronic database to track sales of products containing pseudophedrine. |
Merck & Co., Inc.
|
Ferguson Strategies LLC | |||
Details Regulatory and public policy issues regarding Tricare reimbursement. |
Triax Pharmaceuticals LLC
|
Ferguson Strategies LLC | |||
Details Policy issues related to Public Law 114-225, the 21st Century Cures Act Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act Policy issues relat... |
Pentec Health, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Federal policy issues related to oil and natural gas production. |
DCOR, LLC
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement issues related to medical technology, including diagnostics. |
SQI Diagnostics
|
BAKER & HOSTETLER LLP | |||
Details Legal reform issues; no specific legislation. |
US CHAMBER OF COMMERCE
|
Mayer Brown LLP | |||
Details Policy issues related to outsourcing facilities as defined under Sec. 503B of Public Law No. 113-54, the Drug Quality and Security Act. |
Outsourcing Facilities Association
|
BAKER & HOSTETLER LLP | |||
Details Policy issues regarding healthcare research, including federal funding. |
Southern Research
|
BAKER & HOSTETLER LLP | |||
Details Issues related to Clean Air Act regulations, climate change, stratospheric ozone protection, greenhouse gas reporting, fluorochemicals, hydrofluorocarbons and/or refrigerants; and/or the Montreal P... |
ARKEMA INC.
|
Mayer Brown LLP | |||
Details Policy issues relating to transparency and conflicts of interest in the financial services' proxy advisory industry, and capital markets structure. H.R. 1839, the "Reforming Access for Investments ... |
NASDAQ (formerly NASDAQ OMX Group)
Stock exchange. |
Ferguson Strategies, LLC | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
AbbVie, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
OncoSec Medical Inc.
|
BAKER & HOSTETLER LLP | |||
Details Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies. |
Alcon Vision, LLC
|
BAKER & HOSTETLER LLP | |||
Details Issues relating to implementation of Titles I, VI, VII, IX, and X of the Dodd-Frank Wall Street Reform and Consumer Protection Act, Pub. L. No. 111-203, 124 Stat. 1376 (Juy 21, 2010). |
Royal Bank of Canada
|
Mayer Brown LLP | |||
Details All issues related to financial regulatory reform, H.R. 4173, S. 664. |
Center for Responsible Lending
|
Mercury (formerly known as International Government Relations Group) | |||
Details Issues relating to the defense industry. |
HP Enterprise Services
IT Services Company |
Mercury/Clark & Weinstock (formerly known as Mercury) | |||
Details H.R. 34, the 21st Century Cures Act H.R. 512, the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act S. 145, the Promise for Antibiotics and Therapeutics for Health Ac... |
The Medicines Company
|
BAKER & HOSTETLER LLP | |||
Details Policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act." Policy and implementation issues relating to Public Law No. 112-144, the "Food... |
Dendreon Corp.
|
Ferguson Strategies, LLC | |||
Details Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program and the Me... |
Novartis
|
Ferguson Strategies, LLC | |||
Details television regulations asset forfeiture |
Highway Entertainment
Entertainment |
International Government Relations Group | |||
Details Policy issues relating to the chemistry industry, including the deployment of plastic piping in infrastructure projects. Policy issues relating to tax reform. |
American Chemistry Council
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Cardinal Health, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to financial services, accounting and auditing. |
PwC US Group LLP
|
BAKER & HOSTETLER LLP | |||
Details Policies that advance market transparency, incentivize capital formation, and ensure a robust secondary market for securities trading, and that affect national securities exchange liability, immuni... |
Equity Markets Association
|
BAKER & HOSTETLER LLP | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Gamida
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically related to FDA staffing Policy issues related to Public Law 112-144, the Food and Drug Administration Safety a... |
Portola Pharmaceuticals Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues designed to revitalize the market for small public companies, promote initial public offerings and market transparency, and reduce conflicts of interest in the proxy advisory industry. |
Nasdaq, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Policy issues related to Public Law 114-225, the 21st Century Cures Act, specifically related to combination pharmaceutical products. |
Aralez Pharmaceuticals US, Inc.
|
BAKER & HOSTETLER LLP |